Ceres Ventures, Inc. - FORM 10-K - XML - IDEA: XBRL DOCUMENT - April 13, 2012



Attached files
FileFilename
EX-31.2 - EXHIBIT 31.2 - Ceres Ventures, Inc.v308848_ex31-2.htm
XML - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.R21.htm
XML - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.R19.htm
XML - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.R18.htm
XML - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.R8.htm
EXCEL - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - Ceres Ventures, Inc.R9.htm
EX-32.1 - EXHIBIT 32.1 - Ceres Ventures, Inc.v308848_ex32-1.htm
EX-31.1 - EXHIBIT 31.1 - Ceres Ventures, Inc.v308848_ex31-1.htm
10-K - FORM 10-K - Ceres Ventures, Inc.v308848_10k.htm
v2.4.0.6
SPONSORED RESEARCH AGREEMENT
12 Months Ended
Dec. 31, 2011
SPONSORED RESEARCH AGREEMENT

NOTE 4. SPONSORED RESEARCH AGREEMENT

 

University of California, Santa Barbara

 

On December 9, 2010, the Company entered into the sponsored Research Agreement with the University of California, Santa Barbara (“UCSB”) providing for the continuing development of the UCSB Nanoparticles. The research agreement was effective for the period January 1, 2011 through December 31, 2014. The terms of the agreement were on a “cost reimbursement” basis. The agreement could be terminated by either party, without cause, with a 60-day written notice. Pursuant to SEC Rule 24b-2, certain portions of this agreement have been granted confidential treatment and therefore have not been disclosed.

 

On October 24, 2011, the Company provided a 60-day written termination notice to UCSB as management believes it can further the research and development of the technology on a more cost effective manner than UCSB.

 

Applied Power Concepts, Inc.

 

On July 7, 2011, the Company entered into a services agreement (the “Services Agreement”) with Applied Power Concepts, Inc. (“APC”) and additional ancillary agreements pursuant to which APC assists the Company in the development of the patent pending BluFlow™ Treatment System, which incorporates the BluFlow™ Nanoparticles and BluFlow™ AUT, as well as research and development to determine additional applications for the BluFlow™ Nanoparticles. Pursuant to the terms of the Services Agreement any technologies developed by APC for the Company, including any patents arising therefrom, belong to the Company. Pursuant to SEC Rule 24b-2, certain portions of this agreement have been granted confidential treatment and therefore have not been disclosed.

 

Payment under the Services Agreement is based upon time and materials and includes a bonus of stock options to purchase the Company’s common stock with vesting based on performance milestones. The Services Agreement can be terminated at any time by either party.

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA



This web site and associated pages are not associated with, endorsed by, or sponsored by Ceres Ventures, Inc. and has no official or unofficial affiliation with Ceres Ventures, Inc.


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.